- Home
- HIND
HIND
Vyome Holdings Inc.
as of 08-26-2026 9:30am EST
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
| Founded: | 2017 | Country: | United States |
| Employees: | 2 | City: | SAN CLEMENTE |
| Market Cap: | 15.2M | IPO Year: | 2016 |
| Target Price: | $15.00 | AVG Volume (30 days): | 7.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.24 | EPS Growth: | 64.86 |
| 52 Week Low/High: | $1.75 - $9.69 | Next Earning Date: | 05-20-2026 |
| Revenue: | $319,714 | Revenue Growth: | 24.43% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -9.00 | Index: | N/A |
| Free Cash Flow: | -3919853.0 | FCF Growth: | N/A |
Earnings Transcripts
SEC 8-K filings with transcript text
2026 Q1 Q1 2026 Earnings
8-K May 29, 2026
Q1 2026 Earnings
8-KMay 29, 2026
2025 Q3 Q3 2025 Earnings
8-K Nov 19, 2025
Q3 2025 Earnings
8-KNov 19, 2025
2024 Q3 Q3 2024 Earnings
8-K Nov 14, 2024
Q3 2024 Earnings
8-KNov 14, 2024
Compare HIND vs Leading Stocks
See how HIND stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HIND Vyome Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.